MedicarePartD.guide

A non-government resource built from CMS public data

ZARXIO 300 ug/.5mL Injection, Solution

Also known as Filgrastim-Sndz. Coverage in Connecticut, Massachusetts, Rhode Island and Vermont (CMS PDP Region 02).

5 of 11 stand-alone Part D plans in Connecticut, Massachusetts, Rhode Island and Vermont cover this drug on tier 5.

3 of 5 plans apply a prior authorization, step therapy or quantity limit.

137 Medicare Advantage plans in CT, MA, RI, VT do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. CT: 36 plans · MA: 84 plans · RI: 15 plans · VT: 2 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
Blue MedicareRx Value Plus (PDP)$20.70/mo premium · $615.00 deductible5Specialty Tier25%—$525.0306—
  • Prior authorization
SilverScript Choice (PDP)$32.70/mo premium · $615.00 deductible5Specialty Tier25%—$539.9471—
  • Prior authorization
AARP Medicare Rx Saver from UHC (PDP)$38.70/mo premium · $615.00 deductible5Specialty Tier25%—$552.8440—None
AARP Medicare Rx Preferred from UHC (PDP)$155.10/mo premium · $130.00 deductible5Specialty Tier31%—$552.8440—None
Blue MedicareRx Premier (PDP)$238.60/mo premium · $0.00 deductible5Specialty Tier33%—$525.0306—
  • Prior authorization

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →